VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+42.63%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$906M
AUM Growth
-$90.1M
(-9%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-27.35%
Top 10 Holdings %
Top 10 Hldgs %
57.8%
Holding
54
New
5
Increased
4
Reduced
7
Closed
3
Top Buys
| 1 |
ALLK
Allakos
ALLK
|
$25.2M |
| 2 |
Terns Pharmaceuticals
TERN
|
$19M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$15.3M |
| 4 |
CINC
CinCor Pharma, Inc. Common Stock
CINC
|
$11.5M |
| 5 |
Vaxcyte
PCVX
|
$9.71M |
Top Sells
| 1 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$183M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$85.3M |
| 3 |
Harmony Biosciences
HRMY
|
$30.7M |
| 4 |
Ventyx Biosciences
VTYX
|
$19.8M |
| 5 |
AMRS
Amyris Inc.
AMRS
|
$11.4M |
Sector Composition
| 1 | Healthcare | 97.5% |
| 2 | Materials | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MTCR
51
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $71K | 0.01% |
146,426
| – | – |
|
52
Design Therapeutics
DSGN
$367M
| – | – |
-476,589
| Closed | -$6.67M |
|
53
Zymeworks
ZYME
$1.14B
| – | – |
-286,064
| Closed | -$1.52M |
|
|
SRRA
54
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| – | – |
-3,329,509
| Closed | -$183M |
|